Xinyu Chai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xinyu Chai has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Chao Yu
Chongqing Medical University
1 shared publication Qingsong Jiang
College of Pharmacy, Chongqing Medical University, Chongqing, People’s Republic of China
1 shared publicationSiyi Liu
College of Pharmacy, Chongqing Medical University, Chongqing, People’s Republic of China
1 shared publication- Tingrui Zhao
Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People’s Republic of China
1 shared publication - Tingting Wang
College of Pharmacy, Chongqing Medical University, Chongqing, 400016, PR China; Chongqing Key Laboratory for Pharmaceutical Metabolism Research, Chongqing Medical University, Chongqing, 400016, PR China
1 shared publication Wenming Li
Department of Clinical Laboratory, University-Town Hospital of Chongqing Medical University, Chongqing, People’s Republic of China
1 shared publication
Latest Publications
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 326 (6) , C1563-C1572
Ox-LDL-induced CD80+ macrophages expand pro-atherosclerotic NKT cells via CD1d in atherosclerotic mice and hyperlipidemic patients
This work proposed the ox-LDL-CD80+ monocyte/macrophage-CD1d-NKT cell-IFN-γ axis in the progression of atherosclerosis. The proinflammatory IFN-γ+ NKT cells are closely related to CD1d+CD80+ monocytes in hyperlipidemic patients. Inhibiting CD80+ macrophages to present lipid antigens to NKT cells through CD1d blocking may be a new therapeutic target for atherosclerosis.
- 1 June 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 326 (6) , C1563-C1572
Ox-LDL-induced CD80+ macrophages expand pro-atherosclerotic NKT cells via CD1d in atherosclerotic mice and hyperlipidemic patients
This work proposed the ox-LDL-CD80+ monocyte/macrophage-CD1d-NKT cell-IFN-γ axis in the progression of atherosclerosis. The proinflammatory IFN-γ+ NKT cells are closely related to CD1d+CD80+ monocytes in hyperlipidemic patients. Inhibiting CD80+ macrophages to present lipid antigens to NKT cells through CD1d blocking may be a new therapeutic target for atherosclerosis.